Fresh Atlantic crab wasn’t the only “crunch” being discussed in Baltimore’s scenic Inner Harbor last week, as pioneers and innovators in the field of molecular diagnostics converged on Charm City for the G2 MDx NEXT conference, a 3-day event centered around reimbursement challenges facing healthcare today.
Healthcare as a whole is in a sea of turmoil, but few have borne the brunt of these challenges like those in the diagnostic laboratory. Subjected to constant reimbursement cuts and operational scrutiny, diagnostic medicine is left gasping for air in this sink-or-swim environment. MDx NEXT was a fantastic way for visionaries in the industry to brainstorm and share best practices regarding ways to stay afloat.
Despite erratic weather, hc1.com’s dinner Thursday even at The Rusty Scupper provided a great opportunity for professionals to network and share insight surrounding the reimbursement challenge. We found it interesting – comical, even – how the folks in the lab, working to provide the information responsible for over 70% of all clinical decisions, have once again found themselves at the bottom of the healthcare totem pole.
Issue analysis, reimbursement trends, and identification of repeat trends are all excellent sources of data for optimization as labs look to streamline operations. There has never been a better time to help the labs provide a superior patient experience, and the best way to do so is by harnessing huge amounts of business and clinical data and turning it into real-time intelligence through hc1.com.
A huge thank you to Jonathan Ping and the G2 team for putting together a great event – we look forward to many more!